Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.

The promoter of the human dihydrofolate reductase (DHFR) gene contains two consensus binding sites for the DNA binding protein Sp1. DNAse protection and gel mobility shift assays demonstrate binding of recombinant Sp1 to both decanucleotide Sp1 binding sequences which are located 49 and 14 base pair...

Description complète

Détails bibliographiques

Publié dans:	J Clin Invest
Auteurs principaux:	Blume, S W, Snyder, R C, Ray, R, Thomas, S, Koller, C A, Miller, D M
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 1991
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1834700/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115474
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!